This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
Active as of 2022-09-19 |
Resource Evidence "104156" Version "9" Updated "2023-12-06 00:51:34+0000"
Profiles: ComparativeEvidence, SingleStudyEvidence
StructureDefinition Work Group: cds
url: https://fevir.net/resources/Evidence/104156
identifier: FEvIR Object Identifier: 104156
version: 1.0.0-ballot
name: ComparativeEvidence_Bypass_surgery_effects_on_Treatment_with_opioids_in_JAMA_2018_Norwegian_cohort_study
title: ComparativeEvidence: Bypass surgery effects on Treatment with opioids in JAMA 2018 Norwegian cohort study
status: active
date: 2022-09-19 21:16:36+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
author: Brian S. Alper:
Code | Value[x] |
Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | ComparativeEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#ComparativeEvidence) |
Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | SingleStudyEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#SingleStudyEvidence) |
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
relatedArtifact
type: derived-from
document
relatedArtifact
type: cite-as
citation: ComparativeEvidence: Bypass surgery effects on Treatment with opioids in JAMA 2018 Norwegian cohort study [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 104156. Revised 2022-09-19. Available at: https://fevir.net/resources/Evidence/104156. Computable resource at: https://fevir.net/resources/Evidence/104156.
description: greater risk of treatment with opioids: AR, 19.4% vs 15.8%, RD, 3.6% [95% CI, 2.3%-4.9%], RR, 1.3 [95% CI, 1.2-1.4]
assertion: Compared with specialized medical treatment, bariatric surgery may slightly increase the use of opioids.
variableDefinition
VariableDefinitionVariableRoleCode: population
description: Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included).
note: population
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#population "population")
observed: Group/178427: StudyGroup: Severely Obese Adults 2018 Norwegian Cohort "Severely_Obese_Adults_2018_Norwegian_Cohort"
variableDefinition
VariableDefinitionVariableRoleCode: exposure
VariableDefinitionComparatorCategory: no bariatric surgery
description: bariatric surgery vs. specialized medical treatment without bariatric surgery
note: exposure
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#exposure "exposure")
intended: EvidenceVariable/172427: GroupAssignment: Bariatric Surgery vs. no bariatric surgery "GroupAssignment_Bariatric_Surgery_vs_no_bariatric_surgery"
variableDefinition
VariableDefinitionVariableRoleCode: outcome
description: Treatment with opioids
note: outcome
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#measuredVariable "measured variable")
observed: EvidenceVariable/104119: OutcomeVariable: Treatment with opioids "OutcomeVariable_Treatment_with_opioids"
synthesisType: not applicable (StatisticSynthesisType#NotApplicable)
studyDesign: Observational research (Study Design#SEVCO:01002), Parallel cohort design (Study Design#SEVCO:01011), Longitudinal data collection (Study Design#SEVCO:01028)
statistic
description: Relative risk 1.3; 95% CI 1.2 to 1.4
note: Result observed without bariatric surgery was 15.8%, result observed with bariatric surgery was 19.4%
statisticType: Relative Risk (StatisticStatisticType#C93152)
quantity: 1.3
SampleSizes
NumberOfStudies NumberOfParticipants KnownDataCount 1 1888 1888 AttributeEstimates
Description Type Level Range 95% CI 1.2 to 1.4 Confidence interval (StatisticAttribute Estimate Type#C53324) 0.95 1.2-1.4
Description | Type | Rating |
rated down 2 levels due to observational study | Overall certainty (Evidence Certainty Type#Overall) | Low quality (StatisticCertaintyRating#low) |